Key references: Stepwise therapy for wheeze and asthma: children 1 to 5 years

  • Bisgaard H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, Menten J, et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 2005;171(4):315–22. https://www.ncbi.nlm.nih.gov/pubmed/15542792
  • Brodlie M, Gupta A, Rodriguez-Martinez CE, Castro-Rodriguez JA, Ducharme FM, McKean MC. Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children. Cochrane Database Syst Rev 2015;(10):CD008202. https://www.ncbi.nlm.nih.gov/pubmed/26482324
  • Castro-Rodriguez JA, Rodriguez-Martinez CE, Ducharme FM. Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: a systematic review. Pediatr Pulmonol 2018;53(12):1670–7. https://www.ncbi.nlm.nih.gov/pubmed/30394700
  • Fitzpatrick AM, Jackson DJ, Mauger DT, Boehmer SJ, Phipatanakul W, Sheehan WJ, et al. Individualized therapy for persistent asthma in young children. J Allergy Clin Immunol 2016;138(6):1608-18 e12. https://www.ncbi.nlm.nih.gov/pubmed/27777180
  • Fogel RB, Rosario N, Aristizabal G, Loeys T, Noonan G, Gaile S, et al. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children. Ann Allergy Asthma Immunol 2010;104(6):511–7. https://www.ncbi.nlm.nih.gov/pubmed/20568384
  • Global Initiative for Asthma (GINA)Global strategy for asthma management and prevention: main report. Wisconsin: GINA; 2019. www.ginasthma.org
  • Jartti T. Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma? Eur J Pediatr 2008;167(7):731–6. https://www.ncbi.nlm.nih.gov/pubmed/18214538
  • Kaiser SV, Huynh T, Bacharier LB, Rosenthal JL, Bakel LA, Parkin PC, et al. Preventing exacerbations in preschoolers with recurrent wheeze: a meta-analysis. Pediatrics 2016;137(6). https://www.ncbi.nlm.nih.gov/pubmed/27230765
  • Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, et al. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: a prospective, randomized, double-blind, double-dummy, parallel-group study. Clin Ther 2008;30(8):1492–504. https://www.ncbi.nlm.nih.gov/pubmed/18803991
  • Nagao M, Ikeda M, Fukuda N, Habukawa C, Kitamura T, Katsunuma T, et al. Early control treatment with montelukast in preschool children with asthma: a randomized controlled trial. Allergol Int 2018;67(1):72–8. https://www.ncbi.nlm.nih.gov/pubmed/28526210
  • National Asthma Council AustraliaAustralian Asthma Handbook, v2.1. Melbourne: National Asthma Council Australia; 2020. https://www.asthmahandbook.org.au/
  • Szefler SJ, Carlsson LG, Uryniak T, Baker JW. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma. J Allergy Clin Immunol Pract 2013;1(1):58–64. https://www.ncbi.nlm.nih.gov/pubmed/24229823
  • Valovirta E, Boza ML, Robertson CF, Verbruggen N, Smugar SS, Nelsen LM, et al. Intermittent or daily montelukast versus placebo for episodic asthma in children. Ann Allergy Asthma Immunol 2011;106(6):518–26. https://www.ncbi.nlm.nih.gov/pubmed/21624752